Clinical Trial Update: Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

View source ↗

Summary

This completed trial evaluated whether niacin-induced flushing can serve as a biomarker for cannabis effects on arachidonic acid pathways in people with schizop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Schizophrenia

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: University of Jena | Conditions: Schizophrenia, Cannabis Abuse | Status: COMPLETED